MISSO holds CDSCO approval and is positioned about 66 per cent below imported systems

Meril's MISSO holds CDSCO approval, with CE and United States FDA pending as of June 2024, and is positioned at about 66 per cent below imported robotic knee systems with a claimed success rate of about 98 per cent. Both the price positioning and the success rate are company claims carried by the trade press and must be presented as such.

Supporting location Article body, approval status and price positioning

No current answer cites this record.